In this issue:
- Hypertension risk with teriflunomide vs dimethyl fumarate
- Long-term efficacy of cladribine in MS
- History of head trauma and risk of MS
- Hepatitis B virus infection is prevalent in Taiwanese patients with NMOSD
- Ocrelizumab and the wearing-off phenomenon
- Impact of rituximab dose reduction in patients with NMOSD
- High dose corticosteroids and plasmapheresis in patients with MOGAD or NMOSD
- Impact of natalizumab dosing schedule on fatigue
- Is cervical canal area a marker of disability and progression in MS?
- Peripartum mental illness in mothers with MS
Please login below to download this issue (PDF)